ConductScience.org, home

Disease · MONDO_0006932

pulmonary edema

6 sourcesdiseases-2026-09-18-0.1.0

Download JSON
Cite this record

ConductScience Library. pulmonary edema. Diseases, record MONDO_0006932. Release diseases-2026-09-18-0.1.0, 18 Sept 2026. https://conductscience.org/library/diseases/MONDO_0006932

On this page

Disease

Names and IDs as Open Targets gives them. Its IDs in MeSH, Orphanet, the Disease Ontology and the NCI Thesaurus are those Open Targets states for it.

Name
pulmonary edema
Open Targets
Open Targets ID
MONDO_0006932
Open Targets
Other names
edema, pulmonary, pulmonary oedema
Open Targets
Disease Ontology
DOID:11396
Disease Ontology
MeSH
D011654
MeSH
NCI Thesaurus
C26868
NCI Thesaurus
Highest stage of its drugs
Approval, for 2 of its 9 drugs, from DailyMed
Open Targets

Drugs9

The drugs Open Targets' clinical reports study for the disease, the highest stage first, then the most trial reports. The stage is Open Targets', the highest any of its sources reports for the pair, and each row names the sources that report it.

DrugChEMBL IDTypeOpen Targets' stageStage reported byReportsOf them trialsTrials shown hereSource
ETHACRYNIC ACIDCHEMBL456Small moleculeApprovalDailyMed211Drugs and targets
FUROSEMIDECHEMBL35Small moleculeApprovalDailyMed211Drugs and targets
PRAZOSINCHEMBL2Small moleculePhase 3ClinicalTrials.gov111Drugs and targets
ALBUTEROLCHEMBL714Small moleculePhase 2/3ClinicalTrials.gov222Drugs and targets
SODIUM CHLORIDECHEMBL1200574Small moleculePhase 2ClinicalTrials.gov111Drugs and targets
SILDENAFILCHEMBL192Small moleculeEarly phase 1ClinicalTrials.gov111Drugs and targets
ACETYLCYSTEINECHEMBL600Small moleculeUnknownClinicalTrials.gov110Drugs and targets
DEXAMETHASONECHEMBL384467Small moleculeUnknownClinicalTrials.gov111Drugs and targets
NIFEDIPINECHEMBL193Small moleculeUnknownClinicalTrials.gov111Drugs and targets

Targets11

The targets ChEMBL's mechanism records give for the disease's drugs, through Open Targets, the most drugs first. A mechanism record says what a drug acts on, not that the target causes the disease.

TargetProteinIts drugs that act on itMechanismsHighest stage of those drugsGene in GenesSource
SLC12A1Solute carrier family 12 member 12Sodium-(potassium)-chloride cotransporter 2 inhibitorApprovalhttps://conductscience.org/library/genes/6557Drugs and targets
ADRA1AAdrenergic receptor alpha-11Adrenergic receptor alpha-1 antagonistPhase 3https://conductscience.org/library/genes/148Drugs and targets
ADRA1BAdrenergic receptor alpha-11Adrenergic receptor alpha-1 antagonistPhase 3https://conductscience.org/library/genes/147Drugs and targets
ADRA1DAdrenergic receptor alpha-11Adrenergic receptor alpha-1 antagonistPhase 3https://conductscience.org/library/genes/146Drugs and targets
ADRB2Beta-2 adrenergic receptor1Beta-2 adrenergic receptor agonistPhase 2/3https://conductscience.org/library/genes/154Drugs and targets
CACNA1CVoltage-gated L-type calcium channel1Voltage-gated L-type calcium channel blockerUnknownhttps://conductscience.org/library/genes/775Drugs and targets
CACNA1DVoltage-gated L-type calcium channel1Voltage-gated L-type calcium channel blockerUnknownhttps://conductscience.org/library/genes/776Drugs and targets
CACNA1FVoltage-gated L-type calcium channel1Voltage-gated L-type calcium channel blockerUnknownhttps://conductscience.org/library/genes/778Drugs and targets
CACNA1SVoltage-gated L-type calcium channel1Voltage-gated L-type calcium channel blockerUnknownhttps://conductscience.org/library/genes/779Drugs and targets
NR3C1Glucocorticoid receptor1Glucocorticoid receptor agonistUnknownhttps://conductscience.org/library/genes/2908Drugs and targets

1 to 10 of 11

See all 11 targets

Trials7

Trials an Open Targets clinical report links to the disease, posted results first, then the largest. A trial is shown when the release's checks confirm its link to the disease and Drugs and targets shows its link to one of the disease's drugs. 1 more is not shown, since the checks do not confirm it.

TrialTitlePhaseParticipantsResults first postedConditionsDrugsLinked bySource
NCT00310401The Effect of Nebulized Albuterol on Donor OxygenationPhase 25062013-09-02Brain Death, Organ Donor, Pulmonary EdemaALBUTEROL, SODIUM CHLORIDEIts record names the diseaseClinicalTrials.gov
NCT06188195Establishment and Evaluation of Prenatal Prevention and Treatment Strategy for NARDSNot applicable500Acute Respiratory Distress Syndrome, Respiratory Distress Syndrome, AcuteDEXAMETHASONEIts record names the diseaseClinicalTrials.gov
NCT03945643Is Blood Flow Through IPAVA and PFO Related to Breath-hold and SCUBA Diving-induced Pulmonary Hypertension?Early phase 182Patent Foramen Ovale, Intrapulmonary Arteriovenous AnastamosisSILDENAFILIts record names the diseaseClinicalTrials.gov
NCT00753064AScVS and/ or Prazosin for Scorpion EnvenomationPhase 381Scorpion EnvenomationPRAZOSINIts record names the diseaseClinicalTrials.gov
NCT01628731Furosemide Versus Ethacrynic Acid in Children With Congenital Heart DiseasePhase 374Fluid OverloadETHACRYNIC ACID, FUROSEMIDEIts record names the diseaseClinicalTrials.gov
NCT04288219Non-Invasive Positive Pressure Ventilation Management of High Altitude Pulmonary EdemaNot applicable16High Altitude Pulmonary Edema, Non-Invasive Positive Pressure Ventilation, HypoxiaNIFEDIPINEIts record names the diseaseClinicalTrials.gov
NCT01375361Nebulized Albuterol for Congestive Heart Failure ExacerbationPhase 2/30Congestive Heart FailureALBUTEROLIts record names the diseaseClinicalTrials.gov

Comparisons in its trials2

Comparisons Trial comparisons calculated in the trials shown here, most participants first. A comparison in one of these trials does not always compare a treatment for the disease, so read the two groups.

ComparisonGroup 1, with the outcomeGroup 2, with the outcomeParticipantsTrialSource
Albuterol vs Saline: Number of Donor Lungs Used for Transplantation74 of 26078 of 246506NCT00310401Trial comparisons
Albuterol vs Saline: serious adverse events0 of 2600 of 246506NCT00310401Trial comparisons

Papers from its trials1

The papers the trials shown here list on ClinicalTrials.gov as their results (RESULT) or as drawn from them (DERIVED), results first, newest first.

PMIDListed asTrials listing it
25563826DERIVED1

Source PubMed

Data dates

The date of each source this release read.

Open Targets
2026-09-18
Open Targets
Drug links and their checks, from Drugs and targets
2026-09-18
Drugs and targets
ClinicalTrials.gov, from Trials
2026-11-12
Trials
Comparisons, from Trial comparisons
2026-03-23
Trial comparisons
PubMed, for the checks
2026-11-06
PubMed
MeSH, for the checks
2026-11-10
MeSH

Sources 6

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • NLM's MeSHNLM's terms
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • NLM's MeSHNLM's
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this disease from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/diseases/v1/MONDO_0006932

GET https://conductscience.org/api/diseases/v1/MONDO_0006932/drugs